About
SYnAbs develops and sells monoclonal antibodies for research, diagnostic, and some therapeutic applications. It focuses on difficult targets such as haptens, small molecules, membrane receptors, and transmembrane proteins, and serves labs working in immunology, oncology, inflammation, and related biomedical fields. The company is based in Gosselies, Belgium.
Services
Custom monoclonal antibody development
Generates custom monoclonal antibodies from antigen design through production for difficult targets and requested applications.
Transmembrane protein antibodies
Develops monoclonal antibodies against membrane receptors and other transmembrane proteins, including GPCRs, ion channels, RTKs, IgSF targets, CTLRs, and viral envelope proteins.
Carbohydrate-specific antibodies
Develops antibodies against carbohydrates and polysaccharides.
Epigenetic modifications antibodies
Develops monoclonal antibodies against histone and DNA epigenetic modifications.
Therapeutic cytokine antibodies
Develops monoclonal antibodies against cytokine targets such as IL-34.
Peptide biomarkers antibodies
Develops monoclonal antibodies against peptide biomarkers.
Infectious disease antibodies
Develops monoclonal antibodies against infectious disease targets.
Steroid antibodies
Develops monoclonal antibodies against steroids.
22 more services
- Toxin antibodies
- Anti-DNP irrelevant antibodies
- Anti-GPCR antibodies
- Anti-histone epigenetic modification antibodies
- Anti-MMP9 & IL1B antibodies
- Isotype control antibodies
- Anti-His tag antibodies
- Anti-steroids antibodies
- Anti-small molecules antibodies
- Anti-hemoglobin antibodies
- Secondary anti-mouse monoclonal antibodies
- Secondary anti-rat monoclonal antibodies
- Secondary anti-human monoclonal antibodies
- Secondary anti-chicken monoclonal antibodies
- Secondary anti-rabbit monoclonal antibodies
- Immunoaffinity columns
- Ready-to-use monoclonal antibodies
- Therapeutic monoclonal antibodies
- R&D monoclonal antibodies
- Surrogate antibodies
- Primary monoclonal antibodies
- Secondary monoclonal antibodies
Capabilities
- Assays and studies
- Rodent models
- Antibodies
- Small molecules
- Immunogenicity
- In vivo
- ELISA
13 more
- IHC
- DOT-ELISPOT
- Cryosection
- In vitro diagnostic
- Immunodetection
- Assay development
- Anti-GPCR
- Anti-histone epigenetic modification
- Anti-His tag
- Isotype control
- ADA generation
- Anti-small molecule hapten
- Anti-hemoglobin
- Scale and capacity
- Dozens of projects per year
- More than 1000+ fusions
- Gram manufacturing
- Therapeutic areas
- Oncology
- Allergic diseases
- Infectious diseases
- Cell and gene therapy
- Microbiome
- Epigenetics
- Cell & gene therapy
Modalities and species
- Modalities
- Small molecule
- Antibody
- Peptide
- Species and models
- Rat-LOU
- Mouse
- Rat
- Chicken
- Rabbit
- Human
Certifications
As the company states them, with the certificate or registry record where there is one.
ISO 9001Self-reported
Industries served
- Biotech
- Drug discovery
- In vitro diagnostics
Details
- Founded
- 2015
- Quality
- Quality Policy · Gender Equality Plan · Research Use Only · In Vitro Diagnostic use
- Based in
- Gosselies, Belgium